Capitolis Liquid Global Markets’s Pfizer PFE Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$1.05M Sell
43,700
-205,271
-82% -$5.37M ﹤0.01% 306
2026
Q1
$6.99M Sell
248,971
-147,824
-37% -$3.94M 0.04% 224
2025
Q4
$9.88M Sell
396,795
-1,151,805
-74% -$29M 0.06% 156
2025
Q3
$39.5M Buy
1,548,600
+1,351,000
+684% +$33.3M 0.32% 62
2025
Q2
$4.79M Sell
197,600
-150,000
-43% -$3.5M 0.04% 211
2025
Q1
$8.81M Hold
347,600
0.08% 127
2024
Q4
$9.22M Hold
347,600
0.09% 88
2024
Q3
$10.1M Hold
347,600
0.11% 79
2024
Q2
$9.73M Hold
347,600
0.12% 79
2024
Q1
$9.65M Buy
347,600
+141,000
+68% +$3.91M 0.15% 78
2023
Q4
$5.95M Buy
+206,600
New +$6.25M 0.24% 60

Other funds holding PFE

Capitolis Liquid Global Markets's PFE Position: Q2 2026 in Review

Capitolis Liquid Global Markets reduced its Pfizer (PFE) stake by 82% in Q2 2026, selling an estimated $5.37M and leaving 43,700 shares worth $1.05M. The position accounts for ﹤0.01% of the portfolio, ranked #306.

Capitolis Liquid Global Markets first reported a position in PFE in Q4 2023 and has held it in 11 quarters since. The position peaked at $39.5M in Q3 2025. 2,823 funds tracked by Wall St. Rank hold PFE as of Q2 2026.

  • Capitolis Liquid Global Markets held 43,700 shares of Pfizer worth $1.05M as of Q2 2026.
  • Capitolis Liquid Global Markets sold 205,271 Pfizer shares in Q2 2026, an estimated $5.37M.
  • Pfizer made up ﹤0.01% of Capitolis Liquid Global Markets's portfolio in Q2 2026, its #306 holding.
  • Capitolis Liquid Global Markets first reported a position in Pfizer in Q4 2023 and has held it in 11 quarters since.
  • Capitolis Liquid Global Markets's Pfizer position peaked at $39.5M in Q3 2025.
  • 2,823 funds tracked by Wall St. Rank held Pfizer as of Q2 2026.

Based on Capitolis Liquid Global Markets's 13F filing for Q2 2026, filed 13 Aug 2026.